Back to search
Hypoxic Ischemic Encephalopathy of Newborn
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypoxic Ischemic Encephalopathy of Newborn trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypoxic Ischemic Encephalopathy of Newborn trials you may qualify forTo determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypotherm…
Newborns with mild hypoxic-ischemic encephalopathy usually do not receive cooling treatment. However, some of these newborns may develop neurological problems l…
This study aims to evaluate the effectiveness of therapeutic hypothermia in neonates diagnosed with hypoxic-ischemic encephalopathy (HIE). The study focuses on…
Hypoxic-ischemic encephalopathy (HIE) affects approximately 4,000 to 12,000 persons annually in the United States. Mortality from HIE has been reported up to 60…
This is a phase Ib, open-label, dose-validating and safety study of caffeine in neonates with hypoxic-ischemic encephalopathy (HIE) undergoing therapeutic hypot…
This observational study evaluates functional and developmental outcomes in pediatric participants undergoing a two week intensive multimodal neurorehabilitatio…
This randomized controlled trial aims to evaluate the effect of foot reflexology on comfort levels and physiological parameters in neonates with hypoxic-ischemi…
This study was designed to determine the effects of maternal scent and knitted octopus application on pain in infants born with asphyxia beyond 36 weeks' gestat…
An observational clinical investigation of the NeuroBell EEG Monitor (a portable and wireless EEG monitor).